Newscrate logo

Browse the latest pharmalittle news online for free

Search results for "pharmalittle"

STAT+: Pharmalittle: We’re reading about rising GLP-1 use, a psychedelic therapy for depression, and more
STAT+: Pharmalittle: We’re reading about rising GLP-1 use, a psychedelic therapy for depression, and more

The number of people using injectable obesity treatments is increasing rapidly, and it is leading to declines in obesity, according to a new survey Read more

Stat - Oct 28
STAT+: Pharmalittle: We’re reading about a GSK drug’s comeback, a buyer’s club for a Vertex drug, and more
STAT+: Pharmalittle: We’re reading about a GSK drug’s comeback, a buyer’s club for a Vertex drug, and more

The FDA delivered a split decision on a blood cancer drug from GSK, approving its use in one combination regimen but rejecting another Read more

Stat - Oct 24
STAT+: Pharmalittle: We’re reading about a Moderna setback, CVS playing hardball with Gilead, and more
STAT+: Pharmalittle: We’re reading about a Moderna setback, CVS playing hardball with Gilead, and more

Moderna's experimental vaccine for cytomegalovirus, a cause of disability in newborns, failed in a Phase 3 trial Read more

Stat - Oct 23
STAT+: Pharmalittle: We’re reading about a new Trump drug-pricing probe, Novo’s board shake-up, and more
STAT+: Pharmalittle: We’re reading about a new Trump drug-pricing probe, Novo’s board shake-up, and more

The Trump administration is preparing a new probe into drug-pricing practices among U.S. trading partners, laying the ground for fresh tariffs Read more

Stat - Oct 22
STAT+: Pharmalittle: We’re reading about ESMO cancer trial results, warnings from Moderna co-founder, and more
STAT+: Pharmalittle: We’re reading about ESMO cancer trial results, warnings from Moderna co-founder, and more

Patients with an aggressive form of breast cancer will likely have new treatment options after AstraZeneca and Gilead presented successful trial results Read more

Stat - Oct 20
STAT+: Pharmalittle: We’re reading about FDA vouchers, an IVF drug pricing deal for TrumpRx, and more
STAT+: Pharmalittle: We’re reading about FDA vouchers, an IVF drug pricing deal for TrumpRx, and more

The FDA announced the first nine recipients of the Commissioner’s National Priority Review vouchers, a program offering an expedited drug review Read more

Stat - Oct 17
STAT+: Pharmalittle: We’re reading about GSK and leucovorin, China’s API production, and more
STAT+: Pharmalittle: We’re reading about GSK and leucovorin, China’s API production, and more

CEO Emma Walmsley said GSK has had a minimal role in an effort by the FDA to update the prescribing information of the long-shelved drug leucovorin Read more

Stat - Oct 16
STAT+: Pharmalittle: We’re reading about an experimental Lilly weight loss pill, a big biotech funding deal, and more
STAT+: Pharmalittle: We’re reading about an experimental Lilly weight loss pill, a big biotech funding deal, and more

A Lilly experimental weight loss pill showed superior blood sugar control in diabetic patients across two late-stage clinical trials Read more

Stat - Oct 15
STAT+: Pharmalittle: We’re reading about a troubled Novo plant, pressure on the Novavax board, and much more
STAT+: Pharmalittle: We’re reading about a troubled Novo plant, pressure on the Novavax board, and much more

A troubled Indiana contract manufacturing plant recently acquired by Novo Nordisk is considered to not be in compliance with FDA standards Read more

Stat - Oct 14